These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 5117101)

  • 1. [Medicamentous prevention of hyperbilirubinemia of the newborn. II. Influence of the inductor phenylbutazone on loading with paracetamol in newborn].
    Gmyrek D; Kalz M; Pietsch I
    Dtsch Gesundheitsw; 1971 Aug; 26(34):1618-22. PubMed ID: 5117101
    [No Abstract]   [Full Text] [Related]  

  • 2. [Drug prevention of hyperbilirubinemia of the newborn. 3. Electron microscopic liver findings after treatment with phenylbutazone].
    David H; Gmyrek D; Behrisch D
    Dtsch Gesundheitsw; 1971 Sep; 26(36):1689-93. PubMed ID: 5116100
    [No Abstract]   [Full Text] [Related]  

  • 3. [Prevention of toxic hyperbilirubinemia in premature and mature newborn infants by use of an enzyme-inducing combination: phenobarbital-nikethamide].
    Kintzel HW
    Helv Paediatr Acta; 1973; 30():Suppl:35-7. PubMed ID: 4711239
    [No Abstract]   [Full Text] [Related]  

  • 4. [Prevention of hyperbilirubinemia in premature and newborn infants using orotic acid].
    Hinkel GK; Kintzel HW; Schwarze R
    Dtsch Gesundheitsw; 1972 Dec; 27(51):2414-9. PubMed ID: 4650692
    [No Abstract]   [Full Text] [Related]  

  • 5. [Effect of various drugs on serum bilirubin level in newborn infants].
    Händel A; Hinkel GK; Kintzel HW; Schwarze R
    Padiatr Padol; 1973; 8(3):307-15. PubMed ID: 4715041
    [No Abstract]   [Full Text] [Related]  

  • 6. [Enzyme induction in newborn infants--principles of medicamentous prevention of hyperbilirubinemia].
    Gmyrek D
    Z Arztl Fortbild (Jena); 1973 Jun; 67(12):590-8. PubMed ID: 4772880
    [No Abstract]   [Full Text] [Related]  

  • 7. [Drug prophylaxis of newborn hyperbilirubinemia. 1. Influence of phenylbutazone on the bilirubin level and extracellular space].
    Gmyrek D; Pietsch I; Kalz M; Wiegand U; Schmehl U
    Dtsch Gesundheitsw; 1971 Apr; 26(15):681-7. PubMed ID: 5576703
    [No Abstract]   [Full Text] [Related]  

  • 8. [Prevention of newborn infant hyperbilirubinemia by use of drugs. 8. Recommendation for the use of prevention in combination with a screening test for prognosis].
    Gmyrek D; Bunke H; Cario WR; Daberkow H; Läuter J; Saworra H; Weh L; Syllm-Rapoport I
    Kinderarztl Prax; 1973 Apr; 41(4):174-90. PubMed ID: 4731678
    [No Abstract]   [Full Text] [Related]  

  • 9. [Drug prevention of hyperbilirubinemia in newborn infants. 5. Cumulative effect of the combination of the inductors phenobarbital and nikethamide].
    Gmyrek D; Weh L; Kalz M; Bunke H; Cario WR; Lindenau E; Neumann R; Pietsch I; Scigalla P; Sima K; Syllm-Rapoport I
    Dtsch Gesundheitsw; 1972 Nov; 27(47):2221-7. PubMed ID: 4662684
    [No Abstract]   [Full Text] [Related]  

  • 10. [Clinical experiences using phenobarbital in the prevention of hyperbilirubinemia in mature newborn infants in a controlled study].
    Schambach K; Menzel K
    Z Arztl Fortbild (Jena); 1975 May; 69(10):535-7. PubMed ID: 1199187
    [No Abstract]   [Full Text] [Related]  

  • 11. [Prevention by use of drugs of hyperbilirubinemia in the newborn. VI. Animal experiments and clinical tests of Vasalgin].
    Lindenau E; Cario WR; Grübner I; Juras H; Kalz M; Klinger W; Liersch S; Meyer C; Splinter K; Weh L; Gmyrek D
    Padiatr Grenzgeb; 1972; 11(5):369-79. PubMed ID: 4667525
    [No Abstract]   [Full Text] [Related]  

  • 12. [The influence of a short-time enzyme induction with phenobarbital on hyperbilirubinemia in premature newborns].
    Zwacka G; Frenzel J
    Dtsch Gesundheitsw; 1970 Nov; 25(47):2230-4. PubMed ID: 5487509
    [No Abstract]   [Full Text] [Related]  

  • 13. The control of hyperbilirubinemia in the newborn.
    Stern L
    Clin Obstet Gynecol; 1971 Sep; 14(3):855-68. PubMed ID: 4946207
    [No Abstract]   [Full Text] [Related]  

  • 14. [Increased rate of glucuronidation in the human and animal newborn by therapeutic doses of phenobarbital].
    Windorfer A
    Z Kinderheilkd; 1972; 113(1):33-41. PubMed ID: 5066495
    [No Abstract]   [Full Text] [Related]  

  • 15. Prolonged neonatal hyperbilirubinemia and pregnane-3(alpha),20(beta)-diol in maternal milk.
    Severi F; Rondini G; Zaverio S; Vegni M
    Helv Paediatr Acta; 1970 Nov; 25(5):517-21. PubMed ID: 5493567
    [No Abstract]   [Full Text] [Related]  

  • 16. [Prolonged jaundice of newborn induced by human milk].
    Krauer-Mayer B; Keller M; Hottinger A
    Helv Paediatr Acta; 1968 Feb; 23(1):68-76. PubMed ID: 5693943
    [No Abstract]   [Full Text] [Related]  

  • 17. [Medicamentous enzyme induction and hormonal contraception. Second communication: effects of phenobarbital and phenylbutazone on hormonal contraception (author's transl)].
    Böhm S
    Zentralbl Gynakol; 1980; 102(17):966-73. PubMed ID: 7467939
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ethanol in the prevention of neonatal hyperbilirubinaemia.
    Jouppila P; Koivisto M; Suonio S
    Acta Paediatr Scand; 1973 Sep; 62(5):501-4. PubMed ID: 4754143
    [No Abstract]   [Full Text] [Related]  

  • 19. The influence of sodium glucuronate on hyperbilirubinemia of the newborn-further observations.
    SCHWOB M; PERRY R; BOYER A; HOLT LE; HALLMAN N; BACKMAN A; HJELT L
    Pediatrics; 1960 Apr; 25():686-9. PubMed ID: 14444159
    [No Abstract]   [Full Text] [Related]  

  • 20. [Paracetamol loading in the evaluation of the developing glucuronization function in premature infants].
    Pietsch I; Gmyrek D; David H; Behrisch D; Syllm-Rapoport I
    Padiatr Grenzgeb; 1972; 11(3):171-8. PubMed ID: 4644997
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.